Susceptibility weighted imaging at ultra high magnetic field strengths: Theoretical considerations and experimental results

Magnetic Resonance in Medicine

Volumn 60, Issue 5, 2008, Pages 1155-1168

  Deistung, Andreas ^a   Rauscher, Alexander ^b   Sedlacik, Jan ^c   Stadler, Jörg ^d   Witoszynskyj, Stephan ^e   Reichenbach, Jürgen R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

7T; Magnetic susceptibility; MRI; Phase; SWI

Indexed keywords

MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY; TISSUE;

HIGH FIELD STRENGTHS; HIGH SENSITIVITY; IMAGING PARAMETERS; PHASE; SLICE THICKNESS; SPECIFIC ABSORPTION RATE; SUSCEPTIBILITY WEIGHTED IMAGING; ULTRA-HIGH MAGNETIC FIELDS;

BIOLOGICAL RADIATION EFFECTS;

ABSORPTION; ARTICLE; CONTRAST; CONTROLLED STUDY; GEOMETRY; IN VIVO STUDY; MAGNETIC FIELD; MAGNETISM; MATHEMATICAL MODEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PHANTOM; PHYSICAL PARAMETERS; SENSITIVITY AND SPECIFICITY; SIMULATION; STRENGTH; SUSCEPTIBILITY WEIGHTED IMAGING; THEORETICAL MODEL; THICKNESS; TISSUE; VEIN; VISIBILITY;

EID: 55749099620     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21754     Document Type: Article

References (53)

1. Reichenbach JR, Venkatesan R, Schillinger D, Kido DK, Haacke EM. Small vessels in the human brain: MR-venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997;204:272-277.
2. Haacke EM, Xu Y, Cheng YN, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612-618.
3. Sehgal V, Delproposto Z, Haacke EM, Tong KA, Wycliffe N, Kido DK, Xu Y, Neelavalli J, Haddar D, Reichenbach JR. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005;22:439-450.
4. Thomas B, Somasundaram S, Thamburaj K, Kesavadas C, Gupta AK, Bodhey NK, Kapilamoorthy TR. Clinical applications of susceptibility weighted MR imaging of the brain-A pictorial review. Neuroradiology 2008;50:105-116.
5. Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM. Susceptibility-weighted MR imaging: A review of clinical applications in children. AJNR Am J Neuroradiol 2008;29:9-17.
6. Reichenbach JR, Venkatesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging 1997;7:266-279.
7. Abduljalil AM, Schmalbrock P, Novak V, Chakeres DW. Enhanced gray and white matter contrast of phase susceptibility-weighted images in ultra-high-field magnetic resonance imaging. J Magn Reson Imaging 2003;18:284-290.
8. Rauscher A, Sedlacik J, Barth M, Mentzel HJ, Reichenbach JR. Magnetic susceptibility-weighted MR phase imaging of the human brain. AJNR Am J Neuroradiol 2005;26:736-742.
9. Duyn JH, van Gelderen P, Li TQ, de Zwart JA, Koretsky AP, Fukunaga M. High-field MRI of brain cortical substructure based on signal phase. Proc Natl Acad Sci USA 2007;104:11796-11801.
10. Xu Y, Haacke EM. The role of voxel aspect ratio in determining apparent vascular phase behavior in susceptibility weighted imaging. Magn Reson Imaging 2006;24:155-160.
11. Sedlacik J, Rauscher A, Reichenbach JR. Obtaining blood oxygenation levels from MR signal behavior in the presence of single venous vessels. Magn Reson Med 2007;58:1035-1044.
12. Stanisz GJ, Odrobina EE, Pun J, Escaravage M, Graham SJ, Bronskill MJ, Henkelman RM. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005;54:507-512.
13. Silvennoinen MJ, Clingman CS, Golay X, Kauppinen RA, van Zijl PC. Comparison of the dependence of blood R2 and R2* on oxygen saturation at 1.5 and 4.7 Tesla. Magn Reson Med 2003;49:47-60.
14. Warntjes JB, Dahlqvist O, Lundberg P. Novel method for rapid, simultaneous T1, T2*, and proton density quantification. Magn Reson Med 2007;57:528-537.
15. Peters AM, Brookes MJ, Hoogenraad FG, Gowland PA, Francis ST, Morris PG, Bowtell R. T2* measurements in human brain at 1.5, 3 and 7 T. Magn Reson Imaging 2007;25:748-753.
16. Zhao JM, Clingman CS, Närväinen MJ, Kauppinen RA, van Zijl PC. Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn Reson Med 2007;58:592-597.
17. Rooney WD, Johnson G, Li X, Cohen ER, Kim SG, Ugurbil K, Springer CS. Magnetic field and tissue dependencies of human brain longitudinal 1H2O relaxation in vivo. Magn Reson Med 2007;57:308-318.
18. Yacoub E, Shmuel A, Pfeuffer J, Van De Moortele PF, Adriany G, Andersen P, Vaughan JT, Merkle H, Ugurbil K, Hu X. Imaging brain function in humans at 7 Tesla. Magn Reson Med 2001;45:588-594.
19. Koopmans PJ, Manniesing R, Niessen WJ, Viergever MA, Barth M. MR venography of the human brain using susceptibility weighted imaging at very high field strength. MAGMA 2008;21:149-158.
20. Yacoub E, Duong TQ, Van De Moortele PF, Lindquist M, Adriany G, Kim SG, Ugurbil K, Hu X. Spin-echo fMRI in humans using high spatial resolutions and high magnetic fields. Magn Reson Med 2003;49:655-664.
21. Haacke EM, Brown RW, Thompson MR, Venkatesan R. Magnetic resonance imaging - Physical principles and sequence design. New York: Wiley, 1999. p455.
22. Ladd ME. High-field-strength magnetic resonance: potential and limits. Top Magn Reson Imaging 2007;18:139-152.
23. Springer CS. Physicochemical principles influencing magnetopharmaceuticals. In: Gillies RJ, (editor.) NMR in physiology and biomedicine. New York: Academic Press; 1994. pp 75-99.
24. Reichenbach JR, Haacke EM. High resolution BOLD venographic imaging: A window into brain function. NMR Biomed 2001;14:453-467.
25. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005;40:715-724.
26. 1HT1 and T2 measurements of the MR imaging contrast agents Gd-DTPA and Gd-DTPA BMA at 1.5 T. Eur Radiol 1997;7:264-274.
27. Weisskoff RM, Kiihne S. MRI susceptometry: Image-based measurements of absolute susceptibility of MR contrast agents and human blood. Magn Reson Med 1992;24:375-383.
28. Spees WM, Yablonskiy DA, Oswood MC, Ackerman JJ. Water proton MR properties of human blood at 1.5 Tesla: Magnetic susceptibility, T1, T2, T2*, and non-Lorentzian signal behavior. Magn Reson Med 2001;45:533-542.
29. Noll D, Nishimura D, Makovski A. Homodyne detection in magnetic resonance imaging. IEEE Trans Med Imaging 1991;10:154-163.
30. Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical recipes in C: The art of scientific computing. New York: Cambridge University Press; 1992. pp 636-639.
31. Sedlacik J, Herrmann KH, Rauscher A, Reichenbach JR. SWI using different k-space undersampling mechanisms. Proc ISMRM 2005;13:241.
32. Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM. The NMR phased array. Magn Reson Med 1990;16:192-225.
33. Hammond KE, Lupo LM, Xu D, Kelley DA, Vigneron DB, Nelson SJ. Phase imaging of the human brain at 7T. Proc ISMRM 2007;15:682.
34. Rauscher A, Barth M, Reichenbach JR, Stollberger R, Moser E. Automated unwrapping of MR phase images applied to BOLD MR-Venography at 3 Tesla. J Magn Reson Imaging 2003;18:175-180.
35. Witoszynskyj S, Rauscher A, Reichenbach JR, Barth M. ΦUN (Φase UNwrapping) - Validation of a 2D region-growing phase unwrapping algorithm. Proc ISMRM 2007;15:3436.
36. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: Sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-962.
37. Hallgren P, Sourrander B. The effect of age on the non-haemian iron in the human brain. J Neurochem 1958;3:41-51.
38. Dobre MC, Ugurbil K, Marjanska M. Determination of blood longitudinal relaxation time (T1) at high magnetic field strengths. Magn Reson Imaging 2007;25:733-735.
39. Li TQ, van Gelderen P, Merkle H, Talagala L, Koretsky AP, Duyn J. Extensive heterogeneity in white matter intensity in high-resolution T2*-weighted MRI of the human brain at 7.0 T. Neuroimage 2006;32:1032-1040.
40. Ge Y, Barnes S, Xu Y, Neelavalli J, Grossman RI, Haacke EM. Optimization of phase contrast in susceptibility weighted imaging at 7T. Proc ISMRM 2008;16:878.
41. Haacke EM, Lai S, Yablonskiy D, Lin W. In vivo validation of the BOLD mechanism:Areview of signal changes in gradient echo functional MRI. Int J Imag Syst Technol 1995;6:153-163.
42. Ito H, Kanno I, Kato C, Sasaki T, Ishii K, Ouchi Y, Iida A, Okazawa H, Hayashida K, Tsuyuguchi N, Ishii K, Kuwabara Y, Senda M. Database of normal human cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen measured by positron emission tomography with 15O-labelled carbon dioxide or water, carbon monoxide and oxygen: a multicentre study in Japan. Eur J Nucl Med Mol Imaging 2004;31:635-643.
43. Reichenbach JR, Essig M, Haacke EM, Lee BC, Przetak C, Kaiser WA, Schad LR. High-resolution venography of the brain using magnetic resonance imaging. MAGMA 1998;6:62-69.
44. Reichenbach JR, Barth M, Haacke EM, Klarhöfer M, Kaiser WA, Moser E. High-resolution MR venography at 3.0 Tesla. J Comput Assist Tomogr 2000;24:949-957.
45. Rauscher A, Sedlacik J, Barth M, Witoszynskyj S, Reichenbach JR. Phase map based investigation of intravoxel signal dephasing in gradient echo MRI. Proc ISMRM 2006;14:2792.
46. Sehgal V, Delproposto Z, Haddar D, Haacke EM, Sloan AE, Zamorano LJ, Barger G, Hu J, Xu Y, Prabhakaran KP, Elangovan IR, Neelavalli J, Reichenbach JR. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 2006;24:41-51.
47. Witoszynskyj S, Rauscher A, Reichenbach JR, Barth M. Automated phase unwrapping of MR images at different field strengths using multiple quality maps. Proc ISMRM 2005;13:439.
48. Hammond KE, Mukherjee P, Chang SM, Lupo LM, Xu D, Kelley DA, Vigneron DB, Nelson SJ. Phase imaging of brain tumor patients at 7T. Proc ISMRM 2007;15:835.
49. Ogg RJ, Langston JW, Haacke EM, Steen RG, Taylor JS. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 1999;17:1141-1148.
50. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, Khan A, Ayaz M, Kirsch W, Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1-25.
51. Conturo TE, Smith GD. Signal-to-noise in phase angle reconstruction: Dynamic range extension using phase reference offsets. Magn Reson Med 1990;15:420-437.
52. Vlaardingerbroek MT, den Boer JA. Magnetic resonance imaging - Theory and practice. Berlin: Springer-Verlag; 1999. pp 275-288.
53. Truong TK, Chakeres DW, Scharre DW, Beversdorf DQ, Schmalbrock P. Blipped multi gradient-echo slice excitation profile imaging (bmGESEPI) for fast T2* measurements with macroscopic B0 inhomogeneity compensation. Magn Reson Med 2006;55:1390-1395.